Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Eterna Therapeutics
Eterna Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Eterna Therapeutics
Stock Price
$1.1
2024-10-29
Market Capitalization
$6 M
2024-10-29
Eterna Therapeutics Summary
Company Summary
Overview
Eterna Therapeutics is a company that specializes in therapeutic indication treatment solutions. It develops mRNA cell engineering therapies to repair cellular dysfunction and treat serious illnesses.
Type
Public
Status
Active
Founded
1994
Website
https://eternatx.com/
Cybersecurity rating
Sectors
Healthcare
clinical research
life sciences
pharma
therapy
Homepage
Linkedin
Table of Contents
Competitors
Competitors and Similar Companies
Precision for Medicine
Healthcare - Subsidiary
Axsome Therapeutics
Healthcare - Public
PCRS Network
Healthcare - Private
Alphyn Biologics
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top